Fusion Pharmaceuticals Inc (FUSN)
21.45
-0.04
(-0.19%)
USD |
NASDAQ |
May 03, 16:00
21.44
-0.02
(-0.07%)
After-Hours: 20:00
Fusion Pharmaceuticals Cash from Investing (Quarterly): -5.242M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.242M |
| September 30, 2023 | 13.33M |
| June 30, 2023 | -26.32M |
| March 31, 2023 | -24.53M |
| December 31, 2022 | -42.93M |
| September 30, 2022 | 37.25M |
| June 30, 2022 | 9.641M |
| March 31, 2022 | 19.13M |
| December 31, 2021 | 30.90M |
| September 30, 2021 | 32.22M |
| Date | Value |
|---|---|
| June 30, 2021 | 3.659M |
| March 31, 2021 | -29.00M |
| December 31, 2020 | -155.10M |
| September 30, 2020 | -54.97M |
| June 30, 2020 | -0.168M |
| March 31, 2020 | -0.214M |
| December 31, 2019 | -0.116M |
| September 30, 2019 | -0.189M |
| June 30, 2019 | -0.112M |
| March 31, 2019 | -0.039M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-155.10M
Minimum
Dec 2020
37.25M
Maximum
Sep 2022
-10.15M
Average
-0.168M
Median
Jun 2020
Cash from Investing (Quarterly) Benchmarks
| AstraZeneca PLC | -2.413B |
| Landos Biopharma Inc | 0.063M |
| Perspective Therapeutics Inc | -0.089M |
| Acasti Pharma Inc | -6.554M |
| Aurinia Pharmaceuticals Inc | -6.257M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -17.94M |
| Cash from Financing (Quarterly) | 57.86M |
| Free Cash Flow | -85.69M |
| Free Cash Flow Per Share (Quarterly) | -0.2655 |
| Free Cash Flow Yield | -6.09% |